https://luyelearning.com/wp-content/uploads/2023/10/taller-salud-mental-3-tema-2.mp4 TALLER DE SALUD MENTAL PARA EL PROFESIONAL DE LA SALUD – MÓDULO 3 Expertos profesionales de la salud nos comparten sus experiencias y conocimientos en temas de Salud Mental, Diagnóstico y Tratamiento de Trastornos Mentales, entre otros temas relevantes.
TRASTORNO AFECTIVO BIPOLAR – SEGUIMIENTO EN EL 1ER. NIVEL DE PX. Read More »
https://luyelearning.com/wp-content/uploads/2023/10/taller-salud-mental-3-tema-1.mp4 TALLER DE SALUD MENTAL PARA EL PROFESIONAL DE LA SALUD – MÓDULO 3 Expertos profesionales de la salud nos comparten sus experiencias y conocimientos en temas de Salud Mental, Diagnóstico y Tratamiento de Trastornos Mentales, entre otros temas relevantes.
ESQUIZOFRENIA – SEGUIMIENTO EN EL 1ER. NIVEL DE PX. Read More »
https://luyelearning.com/wp-content/uploads/2023/10/taller-salud-mental-sesion-2-tema-2.mp4 TALLER DE SALUD MENTAL PARA EL PROFESIONAL DE LA SALUD – MÓDULO 2 Expertos profesionales de la salud nos comparten sus experiencias y conocimientos en temas de Salud Mental, Diagnóstico y Tratamiento de Trastornos Mentales, entre otros temas relevantes.
DELIRIUM – IDENTIFICACION Y MANEJO Read More »
https://luyelearning.com/wp-content/uploads/2023/10/taller-salud-mental-sesion-2-tema-1.mp4 TALLER DE SALUD MENTAL PARA EL PROFESIONAL DE LA SALUD – MÓDULO 2 Expertos profesionales de la salud nos comparten sus experiencias y conocimientos en temas de Salud Mental, Diagnóstico y Tratamiento de Trastornos Mentales, entre otros temas relevantes.
IMPACTO DEL TRASTORNO DEPRESIVO EN PACIENTES HOSPITALIZADOS Y CON COMORBILIDADES Read More »
https://luyelearning.com/wp-content/uploads/2023/10/Taller-Salud-Mental-Sesion-1-tema-2.mp4 TALLER DE SALUD MENTAL PARA EL PROFESIONAL DE LA SALUD – MÓDULO 1 Expertos profesionales de la salud nos comparten sus experiencias y conocimientos en temas de Salud Mental, Diagnóstico y Tratamiento de Trastornos Mentales, entre otros temas relevantes.
IDENTIFICACIÓN Y TAMIZAJE DE DEPRESIÓN Read More »
https://luyelearning.com/wp-content/uploads/2023/10/Taller-Salud-Mental-Sesion-1-tema-1.mp4 TALLER DE SALUD MENTAL PARA EL PROFESIONAL DE LA SALUD – MÓDULO 1 Expertos profesionales de la salud nos comparten sus experiencias y conocimientos en temas de Salud Mental, Diagnóstico y Tratamiento de Trastornos Mentales, entre otros temas relevantes.
SALUD MENTAL EN EL PROFESIONAL DE LA SALUD Read More »
Bipolar disorder is a highly heritable condition, which can progress from an asymptomatic period in at-risk individuals to a potentially debilitating illness. Identifying individuals who are at a high risk of developing bipolar disorder may provide an opportunity for early intervention to improve outcomes. The main objective of this systematic review is to provide an overview of prospective
Transitioning to bipolar disorder Read More »
Bipolar disorder is a highly heritable condition, which can progress from an asymptomatic period in at-risk individuals to a potentially debilitating illness. Identifying individuals who are at a high risk of developing bipolar disorder may provide an opportunity for early intervention to improve outcomes. The main objective of this systematic review is to provide an overview of prospective
Transitioning to bipolar disorder Read More »
The principal aim of this review is to highlight recent advances in our understanding of cognitive dysfunction in major depressive disorder (MDD). We review new assessment and treatment approaches, in which cognition and associated psychosocial dysfunction are considered primary outcomes. Current work suggests that cognitive dysfunction reduces occupational productivity, and interferes broadly with domains of day-to-day and social
Cognitive dysfunction in major depressive disorder Read More »
The coronavirus disease 19 (COVID-19) pandemic is having a critical impact on healthcare systems across the world, as well as on mental health in the general population; however, evidence regarding the impact of the COVID-19 pandemic on people living with schizophrenia and on the onset of psychotic symptoms is currently emerging. People living with schizophrenia are at an
Schizophrenia during the COVID-19 pandemic Read More »
The coronavirus disease 19 (COVID-19) pandemic is having a critical impact on healthcare systems across the world, as well as on mental health in the general population; however, evidence regarding the impact of the COVID-19 pandemic on people living with schizophrenia and on the onset of psychotic symptoms is currently emerging. People living with schizophrenia are at an
Schizophrenia during the COVID-19 pandemic Read More »
Type 2 diabetes mellitus (T2DM) negatively affects brain structure and function. Meta-analytical data show that relative to age and sex matched non-psychiatric controls, patients with bipolar disorders have double the risk of T2DM. We review the evidence for association between T2DM and adverse clinical and brain imaging changes in bipolar disorders and summarize studies investigating
Bipolar disorders, type 2 diabetes mellitus, and the brain Read More »
Type 2 diabetes mellitus (T2DM) negatively affects brain structure and function. Meta-analytical data show that relative to age and sex matched non-psychiatric controls, patients with bipolar disorders have double the risk of T2DM. We review the evidence for association between T2DM and adverse clinical and brain imaging changes in bipolar disorders and summarize studies investigating
Bipolar disorders, type 2 diabetes mellitus, and the brain Read More »
Recent studies reviewed indicate an increasing trend of both major and minor depression in patients with diabetes. Depression is also reported to be persistent and chronic in diabetes patients. There is a bidirectional link between depression and diabetes. Diabetes-related distress independently increases the diabetes-related complications. Collaborative care is both applicable and helpful in managing depression in diabetes. Leer texto
Depressive symptoms and disorders in type 2 diabetes mellitus Read More »
Recent studies reviewed indicate an increasing trend of both major and minor depression in patients with diabetes. Depression is also reported to be persistent and chronic in diabetes patients. There is a bidirectional link between depression and diabetes. Diabetes-related distress independently increases the diabetes-related complications. Collaborative care is both applicable and helpful in managing depression in diabetes. Leer texto
Depressive symptoms and disorders in type 2 diabetes mellitus Read More »
Due to bipolar disorder clinical heterogeneity, a plethora of studies have provided new genetic, epigenetic, molecular, and cellular findings associated with its pathophysiology. Genome-wide association studies and epigenetic evidence points to genotype–phenotype interactions associated with inflammation, oxidative stress, abnormalities in signaling pathways, hypothalamic– pituitary–adrenal axis, and circadian rhythm linked to mitochondrial dysfunction in bipolar disorder. Although
Advances in the pathophysiology of bipolar disorder Read More »
Due to bipolar disorder clinical heterogeneity, a plethora of studies have provided new genetic, epigenetic, molecular, and cellular findings associated with its pathophysiology. Genome-wide association studies and epigenetic evidence points to genotype–phenotype interactions associated with inflammation, oxidative stress, abnormalities in signaling pathways, hypothalamic– pituitary–adrenal axis, and circadian rhythm linked to mitochondrial dysfunction in bipolar disorder. Although
Advances in the pathophysiology of bipolar disorder Read More »
Comorbidities can contribute to agitation and can make an accurate differential diagnosis challenging. The ongoing development of rapidly acting novel formulations of antiagitation medications, if successful, may facilitate clinical treatment by providing additional options. Read full text
Agitation in schizophrenia: origins and evidence-based treatment Read More »
Elderly patients with SCH on polypharmacy are less frequently studied, although they represent many patients with SCH. Different potentially inappropriate medication lists and collaboration with clinical pharmacists represent effective strategies for medication optimization. More studies are needed on this topic (e.g., prospective nonrandomized studies). Read full text
Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia Read More »
We advocate considering depression and personality as being more closely related and argue in favour of the development of integrated treatment options tailored to understanding symptoms as being interwoven with a variety of long-standing disturbing personality patterns. Both clinically and conceptually, psychodynamic and schema-focused approaches provide good opportunities to adjust available therapies and they could
Integrated treatment for patients with comorbid depression and personality disorders Read More »
The advent of innovative theories about the pathophysiology of psychiatric disorders has ushered in a new era on the basis of the role of the immune system and inflammation in mediating depression in its multifaceted manifestations. Extensive studies have confirmed the proinflammatory status in depression and causal relationships with neurotransmitter dysregulation. Equally importantly the role
Inflammation and depression but where does the inflammation come from? Read More »
Axonal damage is implicated in the neuropathology of depression and cognitive dysfunction. Consequently, neurofilament light protein is an emerging biomarker with potential in depression and cognitive function. Results are more consistent for cognition, requiring more research to assess neurofilament light protein in depression as well as other psychiatric disorders. Future longitudinal studies are necessary to
Neurofilament light protein as a biomarker in depression and cognitive function Read More »
Translation of evidence regarding physical activity for mental health into routine programmes is critical. Efforts to move beyond solely targeting individual-level barriers to physical activity and address systemic barriers include lack of access to appropriate exercise services. This requires consideration of training needs, service structure and culture change. Read full text
New evidence of reward processing abnormalities in MDD, bipolar disorder and schizophrenia has led to a greater understanding of the neural processes associated with symptomatology common across these conditions (e.g., anhedonia). Dissecting various subcomponents of reward processing that map onto partially different neurobiological pathways and investigating their dysregulation in different psychiatric disorders holds promise for
Reward processing dysfunction in major depression, bipolar disorder and schizophrenia Read More »
Recent studies highlight the importance of adopting a nuanced understanding of mechanisms and moderators that explain the stress–depression link. We also encourage continued engagement in collaborative, open science that uses multiple methods to study the full breadth of human diversity. Read full text
Advances in stress and depression research Read More »
Brain stimulation is widely used in clinical settings; however, there is a lack of understanding about its neurobiological mechanism. Further studies are needed to understand the neurobiology of brain stimulation and how it can be used to treat mood disorders in their diversity, including comorbidities with other illnesses. Read full text
Neaurostimulation as a treatment for mood disorders in patients: recent findings Read More »
The level of CVD comorbidity remains high in SMDs, indicating that most people with SMDs have not benefitted from recent medical advances. A complex interplay between genetic and social vulnerability to CVD, which differs across subgroups of patients, seems to be involved. Further research is required to meet the urgent need for earlier, more efficient
This review indicates that patients with schizophrenia are at increased risk of dying of cancer and of several specific types of cancer. This increased mortality can be reduced if the price of tobacco is increased, if smoking cessation programmes are offered systematically, screening programs better implemented in this highly vulnerable group, and if procedures to
Cancer and schizophrenia Read More »
To reduce prevalence, it is essential to narrow the treatment gaps, provide timely interventions and high- quality treatment, eradicate waiting lists, prescribe antidepressants more cautiously and better managed, consider psychological alternatives, and provide more psychosocial treatment in primary care with physician-assistants. In addition, research is needed on long-term outcome of different treatment modalities, and least
